Cargando…
A Novel Therapeutic Effect of a New Variant of CTLA4-Ig with Four Antennas That Are Terminally Capped with Sialic Acid in the CTLA4 Region
Rheumatoid arthritis (RA) is a multifactorial immune-mediated disease, the pathogenesis of which involves different cell types. T-cell activation plays an important role in RA. Therefore, inhibiting T-cell activation is one of the current therapeutic strategies. Cytotoxic T-lymphocyte antigen 4-immu...
Autores principales: | Piao, Yongwei, Yun, So Yoon, Kim, Hee Soo, Park, Bo Kyung, Ha, Hae Chan, Fu, Zhicheng, Jang, Ji Min, Back, Moon Jung, Shin, In Chul, Won, Jong Hoon, Kim, Dae Kyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622320/ https://www.ncbi.nlm.nih.gov/pubmed/36172704 http://dx.doi.org/10.4062/biomolther.2022.071 |
Ejemplares similares
-
Functional Characteristics of C-terminal Lysine to Cysteine Mutant Form of CTLA-4Ig
por: Kim, Bongi, et al.
Publicado: (2013) -
Effects of CTLA4-Ig on human monocytes
por: Tono, Toshihiro, et al.
Publicado: (2017) -
Blood PD-1(+)TFh and CTLA-4(+)CD4(+) T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis
por: Aldridge, Jonathan, et al.
Publicado: (2021) -
Functional Characterization of Human T Cell Hyporesponsiveness Induced by CTLA4-Ig
por: Rochman, Yrina, et al.
Publicado: (2015) -
CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
por: Cross, A.H., et al.
Publicado: (1994)